The Jerusalem PostTech
Israeli Diabetes App MODI Receives Landmark FDA Clearance
Summarized from The Jerusalem Post by baba
Center-rightCharged tone
Plus
Israeli company DreaMed Diabetes has received FDA clearance for its MODI app, which optimizes insulin dosing for type 2 diabetes patients using injections. The app is named in memory of Modi Amir, who was killed on October 7, and is part of an initiative to memorialize victims through innovation.
The story in 5 lines · by baba
- Israeli startup DreaMed Diabetes received FDA clearance for its MODI insulin dosing app.
- MODI is the first FDA-cleared app for optimizing insulin injections for type 2 diabetes.
- The app provides personalized insulin recommendations directly to patients' smartphones.
- It addresses a gap in diabetes care for the 85% of users who rely on injections.
- The app is named in memory of Modi Amir, a victim of the October 7 attacks.
The Jerusalem Post publishes in English. The key points are summarized above. Read The Jerusalem Post’s full report from the link at the top of the page.
Mentioned
